First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain

Clinical trial NCT07348276 · COMPLETED

Trial details

NCT number: NCT07348276
Sponsor: Invicro
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Progressive Supranuclear Palsy (PSP)Healthy Participants

Start date: 2025-11-17
Primary completion: 2026-03-19
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.